| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Assessment of systemic corticosteroid activity
|
Dluhy, R.G.
|
|
1997
|
91 |
S1 |
p. 32-33
2 p.
|
article
|
| 2 |
Central inflammation is more important than peripheral inflammation
|
Poutler, L.W.
|
|
1997
|
91 |
S1 |
p. 9-10
2 p.
|
article
|
| 3 |
Chairmen's introduction
|
Dahl, R.
|
|
1997
|
91 |
S1 |
p. 1-
1 p.
|
article
|
| 4 |
Clinical issues in paediatric asthma
|
Pedersen, S.
|
|
1997
|
91 |
S1 |
p. 40-41
2 p.
|
article
|
| 5 |
Clinical issues in the treatment of adult asthma
|
Greening, A.P.
|
|
1997
|
91 |
S1 |
p. 38-39
2 p.
|
article
|
| 6 |
Dose-response relationships in determining the safety:efficacy ratio
|
Leff, A.
|
|
1997
|
91 |
S1 |
p. 34-37
4 p.
|
article
|
| 7 |
General factors influencing drug delivery to the lung
|
Ganderton, D.
|
|
1997
|
91 |
S1 |
p. 13-16
4 p.
|
article
|
| 8 |
Is total particle dose more important than particle distribution?
|
Chrystyn, H.
|
|
1997
|
91 |
S1 |
p. 17-19
3 p.
|
article
|
| 9 |
Local versus systemic effects of inhaled drugs
|
Lötvall, J.
|
|
1997
|
91 |
S1 |
p. 29-31
3 p.
|
article
|
| 10 |
Peripheral inflammation is more important than central inflammation
|
Hamid, Q.A.
|
|
1997
|
91 |
S1 |
p. 11-12
2 p.
|
article
|
| 11 |
Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety
|
Derendorf, H.
|
|
1997
|
91 |
S1 |
p. 22-28
7 p.
|
article
|
| 12 |
What dose fraction represents the respirable dose?
|
Bisgaard, H.
|
|
1997
|
91 |
S1 |
p. 20-21
2 p.
|
article
|
| 13 |
What is the nature of asthma and where are the therapeutic targets?
|
Howarth, P.H.
|
|
1997
|
91 |
S1 |
p. 2-8
7 p.
|
article
|
Journal description